Michael Ryskin
Stock Analyst at Bank of America Securities
(4.48)
# 1,117
Out of 5,020 analysts
712
Total ratings
60.3%
Success rate
6.3%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $180 | $166.68 | +7.99% | 26 | Sep 28, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $286.83 | - | 20 | Sep 28, 2026 | |
| PAHC Phibro Animal Health | Reiterated: Sell | $35 | $35.87 | -2.43% | 16 | Aug 27, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Hold | $660 → $665 | $517.75 | +28.44% | 33 | Aug 14, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | $32 → $34 | $21.77 | +56.18% | 36 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Hold | $27 → $31 | $32.46 | -4.50% | 2 | Aug 10, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | n/a | $88.76 | - | 28 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | n/a | $28.35 | - | 9 | Aug 6, 2026 | |
| SDGR Schrödinger | Reiterated: Buy | n/a | $30.46 | - | 23 | Aug 6, 2026 | |
| BRKR Bruker | Reiterated: Buy | n/a | $61.94 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $140 | $265.72 | -47.31% | 48 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.98 | - | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $400 → $415 | $425.53 | -2.47% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $211.76 | +8.61% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.2 | $4.06 | -21.18% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $52 | $76.50 | -32.03% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $174.75 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,481.17 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $145.35 | - | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $19.40 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $161.85 | -1.14% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $304.60 | +18.19% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $260.72 | +7.39% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $69.10 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $265 | $231.09 | +14.67% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $365.01 | +12.33% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $630 → $650 | $652.51 | -0.38% | 30 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.4 | $1.65 | +45.90% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $16 | $17.78 | -10.01% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $149.06 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $49 | $42.04 | +16.56% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $15.03 | -26.81% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $7.50 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $9.34 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 | $12.50 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $2.4 | $10.75 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $4.07 | n/a | 2 | Apr 18, 2022 |
Agilent Technologies
Sep 28, 2026
Reiterated: Buy
Price Target: $180
Current: $166.68
Upside: +7.99%
Charles River Laboratories International
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $286.83
Upside: -
Phibro Animal Health
Aug 27, 2026
Reiterated: Sell
Price Target: $35
Current: $35.87
Upside: -2.43%
IDEXX Laboratories
Aug 14, 2026
Reiterated: Hold
Price Target: $660 → $665
Current: $517.75
Upside: +28.44%
Elanco Animal Health
Aug 12, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $21.77
Upside: +56.18%
Alamar Biosciences
Aug 10, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $32.46
Upside: -4.50%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $88.76
Upside: -
Caris Life Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.35
Upside: -
Schrödinger
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.46
Upside: -
Bruker
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $61.94
Upside: -
Aug 5, 2026
Reiterated: Sell
Price Target: $140
Current: $265.72
Upside: -47.31%
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.98
Upside: -
Aug 4, 2026
Reiterated: Hold
Price Target: $400 → $415
Current: $425.53
Upside: -2.47%
Aug 3, 2026
Reiterated: Buy
Price Target: $230
Current: $211.76
Upside: +8.61%
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $4.06
Upside: -21.18%
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $76.50
Upside: -32.03%
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $174.75
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,481.17
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $145.35
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: n/a
Current: $19.40
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $161.85
Upside: -1.14%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $304.60
Upside: +18.19%
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $260.72
Upside: +7.39%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $69.10
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $245 → $265
Current: $231.09
Upside: +14.67%
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $365.01
Upside: +12.33%
Jul 23, 2026
Reiterated: Buy
Price Target: $630 → $650
Current: $652.51
Upside: -0.38%
Jul 15, 2026
Reiterated: Sell
Price Target: $2.4
Current: $1.65
Upside: +45.90%
Jul 13, 2026
Reiterated: Hold
Price Target: $11 → $16
Current: $17.78
Upside: -10.01%
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $149.06
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: $56 → $49
Current: $42.04
Upside: +16.56%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $15.03
Upside: -26.81%
Mar 3, 2025
Reiterated: Buy
Price Target: $9 → $8
Current: $7.50
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $9.34
Upside: n/a
Jul 18, 2024
Reiterated: Sell
Price Target: $10
Current: $12.50
Upside: n/a
Apr 24, 2023
Reiterated: Sell
Price Target: $10 → $2.4
Current: $10.75
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $4.07
Upside: n/a